Gene · 538
Papers3,096
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 3,096
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Copper and Colorectal Cancer. | Cancers (Basel) | 2024 | 39518128 | PubTator, text mining | PubMed |
| Identification and validation of novel genes related to immune microenvironment in polycystic ovary syndrome. | Medicine (Baltimore) | 2024 | 39470566 | PubTator, text mining | PubMed |
| The epidemiology and impact of persistent Campylobacter infections on childhood growth among children 0-24 months of age in resource-limited settings. | EClinicalMedicine | 2024 | 39380966 | PubTator, text mining | PubMed |
| Novel, likely pathogenic variant in ATP7A associated with Menkes disease diagnosed with ultrarapid genome sequencing. | BMJ Case Rep | 2024 | 39353672 | PubTator, text mining | PubMed |
| Analysis of ATP7A Expression and Ceruloplasmin Levels as Biomarkers in Patients Undergoing Neoadjuvant Chemotherapy for Advanced High-Grade Serous Ovarian Carcinoma. | Int J Mol Sci | 2024 | 39337685 | PubTator, text mining | PubMed |
| Copper metabolism-related signature for prognosis prediction and MMP13 served as malignant factor for breast cancer. | Heliyon | 2024 | 39315182 | PubTator, text mining | PubMed |
| CRISPR-Cas9 gene editing strengthens cuproptosis/chemodynamic/ferroptosis synergistic cancer therapy. | Acta Pharm Sin B | 2024 | 39309486 | PubTator, text mining | PubMed |
| TRIM24-DTNBP1-ATP7A mediated astrocyte cuproptosis in cognition and memory dysfunction caused by Y2O3 NPs. | Sci Total Environ | 2024 | 39304169 | PubTator, text mining | PubMed |
| Pan-cancer analysis reveals copper transporters as promising potential targets. | Heliyon | 2024 | 39281483 | PubTator, text mining | PubMed |
| Interleukin-6 induces nascent protein synthesis in human dorsal root ganglion nociceptors primarily via MNK-eIF4E signaling. | Neurobiol Pain | 2024 | 39156884 | PubTator, text mining | PubMed |
| Plumbagin's Antiproliferative Mechanism in Human Cancer Cells: A Copper-Dependent Cytotoxic Approach. | Chem Biol Drug Des | 2024 | 39147940 | PubTator, text mining | PubMed |
| MNK-driven eIF4E phosphorylation regulates the fibrogenic transformation of mesenchymal cells and chronic lung allograft dysfunction. | J Clin Invest | 2024 | 39145446 | PubTator, text mining | PubMed |
| Remodelling of the translatome controls diet and its impact on tumorigenesis. | Nature | 2024 | 39143206 | PubTator, text mining | PubMed |
| Selective and effective suppression of pancreatic cancer through MNK inhibition. | Immunopharmacol Immunotoxicol | 2024 | 39138614 | PubTator, text mining | PubMed |
| Impaired cellular copper regulation in the presence of ApoE4. | J Neurochem | 2024 | 39135362 | PubTator, text mining | PubMed |
| Structural insights into trypanosomatid Mnk kinase orthologues (kMnks) suggest altered mechanism in the kinase domain. | Int J Biol Macromol | 2024 | 39097052 | PubTator, text mining | PubMed |
| Therapeutic effect of small extracellular vesicles from cytokine-induced memory-like natural killer cells on solid tumors. | J Nanobiotechnology | 2024 | 39075563 | PubTator, text mining | PubMed |
| Tomivosertib reduces ectopic activity in dorsal root ganglion neurons from patients with radiculopathy. | Brain | 2024 | 39046204 | PubTator, text mining | PubMed |
Corrigendum to "Protein phosphatase 2A negatively regulates eukaryotic initiation factor 4E phosphorylation and eIF4F assembly through direct dephosphorylation of Mnk and eIF4E" [Neoplasia, volume 12, issue 10 (2010):848 -855]. | Neoplasia | 2024 | 39029162 | PubTator, text mining | PubMed |
| The impact of copper on bone metabolism. | J Orthop Translat | 2024 | 39021399 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/538/papers?page=9